Latest News for: sll

Edit

BeOne Medicines’ Novel BCL2 Inhibitor, Sonrotoclax, Achieves First-in-World Approval in R/R MCL and R/R CLL/SLL (BeOne Medicines AG)

Public Technologies 06 Jan 2026
... lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) globally ... In the Phase 2 open-label study of patients with R/R CLL/SLL treated with sonrotoclax (n=100), ORR as assessed by IRC was 77%.
  • 1

Article Search

tools
×
×
×
×